Clinical Trial Update: Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer [NA]

View source ↗

Summary

Completed safety and tolerability trial evaluating intravesical mitomycin C mixed with a TC-3 drug-retaining hydrogel device in patients with muscle-invasive bl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• Mitomycin-C (mitomycin C)

Snippet

Sponsor: UroGen Pharma Ltd. | Conditions: Carcinoma of Urinary Bladder, Invasive | NA | Status: COMPLETED